dc.contributor.author | Dagoglu, Nergiz | |
dc.contributor.author | Karabulut, Senem | |
dc.contributor.author | Gonenc, Murat | |
dc.contributor.author | Tas, Faruk | |
dc.contributor.author | Serilmez, Murat | |
dc.contributor.author | Afsar, Cıgdem Usul | |
dc.contributor.author | Karabulut, Mehmet | |
dc.contributor.author | Alis, Halil | |
dc.date.accessioned | 2021-03-03T13:38:18Z | |
dc.date.available | 2021-03-03T13:38:18Z | |
dc.identifier.citation | Afsar C. U. , Karabulut M., Karabulut S., Alis H., Gonenc M., Dagoglu N., Serilmez M., Tas F., "Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma", JOURNAL OF INFECTION AND CHEMOTHERAPY, cilt.23, ss.196-200, 2017 | |
dc.identifier.issn | 1341-321X | |
dc.identifier.other | vv_1032021 | |
dc.identifier.other | av_352818fe-aadc-4722-864b-19cc2c91d7ba | |
dc.identifier.uri | http://hdl.handle.net/20.500.12627/39941 | |
dc.identifier.uri | https://doi.org/10.1016/j.jiac.2016.12.003 | |
dc.description.abstract | Background: This study was conducted to investigate the serum levels of interleukin-18 (IL-18) in patients with pancreatic adenocarcinoma (PA) and the relationship with tumor progression and known prognostic parameters. | |
dc.language.iso | eng | |
dc.subject | Temel Eczacılık Bilimleri | |
dc.subject | Yaşam Bilimleri | |
dc.subject | Temel Bilimler | |
dc.subject | Sağlık Bilimleri | |
dc.subject | Eczacılık | |
dc.subject | Farmakoloji ve Toksikoloji | |
dc.subject | FARMAKOLOJİ VE ECZACILIK | |
dc.subject | Yaşam Bilimleri (LIFE) | |
dc.subject | İmmünoloji | |
dc.subject | BULAŞICI HASTALIKLAR | |
dc.title | Circulating interleukin-18 (IL-18) is a predictor of response to gemcitabine based chemotherapy in patients with pancreatic adenocarcinoma | |
dc.type | Makale | |
dc.relation.journal | JOURNAL OF INFECTION AND CHEMOTHERAPY | |
dc.contributor.department | Istanbul Training & Research Hospital , , | |
dc.identifier.volume | 23 | |
dc.identifier.startpage | 196 | |
dc.identifier.endpage | 200 | |
dc.contributor.firstauthorID | 2195190 | |